Paresh Mohanty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paresh Mohanty has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Neethu K. M.
Department of Chemical Sciences, Indian Institute of Science Education and Research Berhampur, Laudigam, Konisi, District Ganjam, Odisha 760003, India
2 shared publications - Parikshit Moitra
Department of Chemical Sciences, Indian Institute of Science Education and Research Berhampur, Laudigam, Konisi, District Ganjam, Odisha 760003, India
2 shared publications Atanu Pal
Department of Nephrology, Institute of Post Graduate Medical Education and Research, Kolkata 700071, India
1 shared publication- Chinmay Saha
Department of Endocrinology and Metabolism Institute of Post Graduate Medical Education & Research and Seth Sukhlal Karnani Memorial Hospital Kolkata India
1 shared publication - Chiranjit Bose
Department of Endocrinology & Metabolism , Institute of Post Graduate Medical Education & Research and SSKM Hospital , Kolkata , West Bengal, India
1 shared publication - Gunjan Verma
Bhabha Atomic Research Centre
1 shared publication
Latest Publications
- Open Access
- 3 August 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (70) , e77429
Nucleotide Driven Hierarchical Self‐Assembly of Covalent Organic Framework and Gold Nanostar for Molecular Diagnosis of Turner Syndrome
Turner Syndrome (TS), a rare chromosomal disorder, cause significant phenotypical changes like growth failure and primary ovarian insufficiency. Chromosomal karyotyping, the preferred diagnostic method till date, resulting in delayed diagnosis that precludes early intervention. Hence, there is a clear unmet clinical need for rapid and cost‐effective diagnostic tool for TS. The current study focuses on developing a multiplexed molecular sensing platform that couples post‐synthetically modified, emissive COF with gold‐nanostars and gene‐specific oligonucleotides to detect TS‐associated DNA. The sensing mechanism relies on a unique self‐organization of this nucleotide decorated 2D‐COF assemblies and 3D‐gold‐nanostars in presence of their target DNA sequence. This nucleotide‐driven 2D‐3D self‐organization translates molecular recognition into convergent, trimodal readouts, i.e., fluorescence, UV–Vis, and photoacoustic scattering, from a single material construct. Responses from nineteen different rare diseased samples toward the sensor platform are compared against healthy specimens. The developed sensor has been observed to quantitatively distinguish gene‐level signatures spanning SHOX, ARSE, XIST, and VAMP7, achieving limits of detection down to 5.2–61.2 pg/mL and diagnostic accuracy up to >95% for XIST when benchmarked against gold standard methods. This programmable supramolecular assembly might have the potential to become an integral part of newborn screening programs, offering early therapeutic opportunities for TS‐affected individuals.
- 3 August 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (70) , e77429
Open AccessNucleotide Driven Hierarchical Self‐Assembly of Covalent Organic Framework and Gold Nanostar for Molecular Diagnosis of Turner Syndrome
Turner Syndrome (TS), a rare chromosomal disorder, cause significant phenotypical changes like growth failure and primary ovarian insufficiency. Chromosomal karyotyping, the preferred diagnostic method till date, resulting in delayed diagnosis that precludes early intervention. Hence, there is a clear unmet clinical need for rapid and cost‐effective diagnostic tool for TS. The current study focuses on developing a multiplexed molecular sensing platform that couples post‐synthetically modified, emissive COF with gold‐nanostars and gene‐specific oligonucleotides to detect TS‐associated DNA. The sensing mechanism relies on a unique self‐organization of this nucleotide decorated 2D‐COF assemblies and 3D‐gold‐nanostars in presence of their target DNA sequence. This nucleotide‐driven 2D‐3D self‐organization translates molecular recognition into convergent, trimodal readouts, i.e., fluorescence, UV–Vis, and photoacoustic scattering, from a single material construct. Responses from nineteen different rare diseased samples toward the sensor platform are compared against healthy specimens. The developed sensor has been observed to quantitatively distinguish gene‐level signatures spanning SHOX, ARSE, XIST, and VAMP7, achieving limits of detection down to 5.2–61.2 pg/mL and diagnostic accuracy up to >95% for XIST when benchmarked against gold standard methods. This programmable supramolecular assembly might have the potential to become an integral part of newborn screening programs, offering early therapeutic opportunities for TS‐affected individuals.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
A covalent organic framework-based fluorescent immunosensor for selective NGAL detection enabling diabetic kidney disease stratification
A covalent organic framework based fluorescent immunosensor enables rapid stratification of diabetic kidney disease with >90% sensitivity, specificity and accuracy.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
A covalent organic framework-based fluorescent immunosensor for selective NGAL detection enabling diabetic kidney disease stratification
A covalent organic framework based fluorescent immunosensor enables rapid stratification of diabetic kidney disease with >90% sensitivity, specificity and accuracy.